Currently Viewing:
Kidney Week 2019
Time to Focus on Increasing Organs for Patients With ESRD, Azar Says at Kidney Week
November 07, 2019
Dr Tammy Brady Discusses the Role of the Pediatric Nephrologist on the Care Team for Metabolic Syndrome
November 07, 2019
Dr Danielle Kirkman Explains How Exercise Testing in Patients With CKD Can Improve Care
November 07, 2019
Dr Cynthia Delgado on the Importance of Patient Input in Kidney Disease Care
November 08, 2019
Data From 3 Roxadustat Trials Lead Off Kidney Week Sessions Ahead of Efficacy, Safety News
November 08, 2019
Dr Joseph Vassalotti Presents Findings of AJMC® Study on CKD Intervention
November 08, 2019
Dr Alan Kliger Outlines Major Safety Risks for Patients Receiving Dialysis
November 08, 2019
Researchers Develop Tool to Identify Those at Risk of Future CKD
November 08, 2019
Paul Conway: Respect, Listening Are Keys to Engaging Patients in Kidney Care
November 08, 2019
Pooled Cardiovascular Data on Roxadustat Show No Increased Risk to Patients With CKD
November 08, 2019
Dr Jay Wish Explains Implications of New Roxadustat Data
November 09, 2019
Patients on Dialysis Have More Hospitalizations in Areas With More Black Residents
November 09, 2019
Physicians, Patient Discuss Intentional Nonadherence in Hypertension Therapy
November 10, 2019
Dr Holly Kramer Discusses Components of the Advancing American Kidney Health Initiative
November 11, 2019
Early Warning Signs of CKD Going Unnoticed in Veterans, Especially Those With Hypertension
November 11, 2019
As Kidney Week Ends, Providers Are Urged to Join New Care Models
November 11, 2019
Understanding More About Quality of Life Impact for Patients With CKD, Anemia
November 11, 2019
Dr Tammy Brady Explains Special Considerations in Pediatric Nephrology
December 05, 2019
Dr Danielle Kirkman Discusses the Biological Relationship Between Exercise and Hypertension
December 10, 2019
Currently Reading
Dr Joseph Vassalotti on How Risk Stratification Informed a Primary Care CKD Intervention
December 11, 2019
Dr Joseph Vassalotti Discusses Upstream Interventions Based on CKD Risk Stratification
December 20, 2019
Dr Danielle Kirkman on the Integration of Exercise Into the CKD Care Plan
December 23, 2019
Dr Tammy Brady Describes Efforts to Improve Diagnosis of Hypertension in Children
December 24, 2019
Dr Tammy Brady on Exciting Advances in Pediatric Nephrology
December 30, 2019

Dr Joseph Vassalotti on How Risk Stratification Informed a Primary Care CKD Intervention

Population health screening involves risk stratification that allows interventions to be targeted to appropriate patients, as was demonstrated in a study of a chronic kidney disease (CKD) intervention published in the November issue of The American Journal of Managed Care®, said lead author Joseph Vassalotti, MD, clinical professor at Icahn School of Medicine at Mount Sinai and chief medical officer of the National Kidney Foundation.


Population health screening involves risk stratification that allows interventions to be targeted to appropriate patients, as was demonstrated in a study of a chronic kidney disease (CKD) intervention published in the November issue of The American Journal of Managed Care®, said lead author Joseph Vassalotti, MD, clinical professor at Icahn School of Medicine at Mount Sinai and chief medical officer of the National Kidney Foundation.

Transcript

What is the importance of CKD screening and detection for population health?

One of the most important things for population health screening is to not only stratify the risk, but also stratify the interventions accordingly. We stratified the interventions including things like risk factor control for diabetes, medical nutrition therapy for diabetes and hypertension, pharmacist evaluation for drug safety interactions, dose adjustment for reduced kidney function, and nephrology consultation for advanced disease, as well as preparation for kidney replacement therapy. All of those were incorporated in a stepwise fashion into the patient-centered medical home population. There was an incentive for the primary care clinician that was upside only to meet cost containment, to meet some quality improvement measures that included both diabetes and hypertension management as well as kidney disease management.

 
Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up